About Project

Nine africans partners are involved in this project such are Benin, Cameroon, Democratic Republic of Congo,  Ethiopia, Guinea, Mali, Nigeria, Rwanda and Senegal.

 

In some African partners (Benin and Rwanda) with advanced molecular laboratories,  the ‘Deeplex’ assay, a novel multiplex deep sequencing-based drug resistance diagnostic platform that simultaneously provides sequence information of genes that confer resistance to severals key anti-TB drugs has been implemented.

DSC_0030_edited.jpg

Welcome On Diama Project

(Diagnosis of Multidrug resistant tuberculosis in Africa) website

The DIAMA (DIAgnostics for Multidrug resistant tuberculosis in Africa) study aims to address current gaps in the diagnosis and management of patients with Multi-Drug-Resistant (MDR) tuberculosis (TB).

Who We are?

A network of West, Central, East African as well as European instititions

Our Mission

To evaluate and implement rapid and accurate molecular tests for the management of drug resistant tuberculosis to replace the current dependency on culture.

Our Vision

To live in a world where drug resistant tuberculosis is managed without culture

Latest News & Events

Subscribe To Our Newsletter

For The Latest Updates, News and Events

Our Project Highlights

1/2
itg_logo_2017_footer.png
logo_tdr.gif
Capture.PNG
Logo_SRL.png
Coordinated by
The Supra National Reference Laboratory of Mycobacteria, Cotonou, Benin
This project is part of the EDCTP2 programme supported by the European Union
Contact Info
Lazaret, Akpakpa, Cotonou, Benin
Tel: 00229 66 61 48 62
 
Email: affolabi_dissou@yahoo.fr
            abenimas@gmail.com
  • Facebook
  • Twitter
  • Instagram
Quick Links
© Copyright 2020 by Diama-Project. Designed by NA Developers.